| NCT ID | NCT06128317 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Heidelberg |
| Condition | Acute Coronary Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,500 participants |
| Start Date | 2014-08-01 |
| Primary Completion | 2030-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,500 participants in total. It began in 2014-08-01 with a primary completion date of 2030-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The single-center MIR-registry was created to assess real-world prevalence, demographic characteristics and management of patients with acute coronary syndrome presenting in the emergency department (ED) of University of Heidelberg.
Eligibility Criteria
Inclusion Criteria: The study will include consecutive patients who present to the cardiology emergency department at Heidelberg University Hospital with symptoms of acute coronary syndrome or a troponin increase (hs-TnT \>14 ng/L). Additional inclusion criteria are a minimum age of 18 years and providing informed consent through written consent to participate in the study. The following medical conditions are intended to be distinguished from one another: * Acute myocardial infarction * Unstable angina pectoris * Myocarditis * Heart failure * Cardiomyopathies * Pulmonary embolism * Renal insufficiency * Supraventricular and ventricular tachycardias * Hypertensive crisis * Non-cardiac chest pain Exclusion Criteria: Exclusion criteria are defined according to GCP (Good Clinical Practice), i.e., mental illnesses/dementia (lack of capacity to provide informed consent), pregnancy/breastfeeding, as well as acute conditions requiring immediate treatment (e.g., cardiogenic shock).
Frequently Asked Questions
Who can join the NCT06128317 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Coronary Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06128317 currently recruiting?
Yes, NCT06128317 is actively recruiting participants. Visit ClinicalTrials.gov or contact University Hospital Heidelberg to inquire about joining.
Where is the NCT06128317 trial being conducted?
This trial is being conducted at Heidelberg, Germany.
Who is sponsoring the NCT06128317 clinical trial?
NCT06128317 is sponsored by University Hospital Heidelberg. The trial plans to enroll 2,500 participants.